BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29783288)

  • 1. Translating pharmacogenomics into personalized medicine and drug development.
    Zhang W; Chan TY; Fan L; Guo Y; Zhou HH
    Per Med; 2012 Jan; 9(1):93-97. PubMed ID: 29783288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics: current applications and future prospects towards personalized therapeutics.
    Vaiopoulou A; Gazouli M; Karikas GA
    J BUON; 2013; 18(3):570-8. PubMed ID: 24065466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics: historical perspective and current status.
    Kalow W
    Methods Mol Biol; 2005; 311():3-15. PubMed ID: 16100395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.
    Squassina A; Manchia M; Manolopoulos VG; Artac M; Lappa-Manakou C; Karkabouna S; Mitropoulos K; Del Zompo M; Patrinos GP
    Pharmacogenomics; 2010 Aug; 11(8):1149-67. PubMed ID: 20712531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized pharmacotherapy in psychiatry.
    Filaković P; Petek A
    Psychiatr Danub; 2009 Sep; 21(3):341-6. PubMed ID: 19794353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine.
    Kalow W
    Pharmacogenomics J; 2006; 6(3):162-5. PubMed ID: 16415920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics steps toward personalized medicine.
    Xie HG; Frueh FW
    Per Med; 2005 Nov; 2(4):325-337. PubMed ID: 29788578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
    Zaza G; Granata S; Mangino M; Grandaliano G; Schena FP
    G Ital Nefrol; 2010; 27(4):353-66. PubMed ID: 20672232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics: implementing personalized medicine.
    Mini E; Nobili S
    Clin Cases Miner Bone Metab; 2009 Jan; 6(1):17-24. PubMed ID: 22461093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.
    Manolopoulos VG; Ragia G; Tavridou A
    Pharmacogenomics; 2011 Aug; 12(8):1161-91. PubMed ID: 21843065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of pharmacogenomics for developing countries in Europe.
    Mitropoulos K; Johnson L; Vozikis A; Patrinos GP
    Drug Metabol Drug Interact; 2011; 26(4):143-6. PubMed ID: 22017487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
    Morley KI; Hall WD
    J Mol Med (Berl); 2004 Jan; 82(1):21-30. PubMed ID: 14598045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic databases in pharmacogenomics: the Frequency of Inherited Disorders Database (FINDbase).
    Georgitsi M; Patrinos GP
    Methods Mol Biol; 2013; 1015():321-36. PubMed ID: 23824866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research.
    Kennedy MA; Joyce PR; Begg EJ
    Pharmacogenomics; 2012 Jun; 13(8):865-8. PubMed ID: 22676191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
    Wei CY; Lee MT; Chen YT
    Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?
    Dreussi E; Biason P; Toffoli G; Cecchin E
    Pharmacogenomics; 2012 Nov; 13(14):1635-50. PubMed ID: 23148639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating pharmacogenomics: challenges on the road to the clinic.
    Swen JJ; Huizinga TW; Gelderblom H; de Vries EG; Assendelft WJ; Kirchheiner J; Guchelaar HJ
    PLoS Med; 2007 Aug; 4(8):e209. PubMed ID: 17696640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics: from cell to clinic (Part 1).
    Siest G; Medeiros R; Melichar B; Stathopoulou M; Van Schaik RH; Cacabelos R; Abt PM; Monteiro C; Gurwitz D; Queiroz J; Mota-Filipe H; Ndiaye NC; Visvikis-Siest S
    Pharmacogenomics; 2014 Apr; 15(5):593-9. PubMed ID: 24798716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.